There is nothing specific about PAR management rather the market has marked down PR for creating repetitious milestone ambiguity.
When it comes to investing and in particular biotechs you have to embrace the process and most importantly be willingly to shoulder the inherent uncertainty and pain that comes with it.
There is nothing specific about PAR management rather the market...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.010(3.85%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.0¢ | $216.0K | 855.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 48298 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 119065 | 4 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
-0.010 ( 5.99 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 26.0¢ | 24.5¢ | 235895 | ||
| Last updated 15.56pm 21/05/2024 ? | |||||
| PAR (ASX) Chart |